Clinical observation on combination of compound xuanju capsule and clomiphene citrate in treating ovulatory dysfunctional infertility patients of Shen-yang deficiency.
- Author:
Ke MA
1
;
Xiao-Ying YU
;
Yi-Feng PENG
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Anovulation; complications; drug therapy; Clomiphene; therapeutic use; Drugs, Chinese Herbal; therapeutic use; Female; Fertility Agents, Female; therapeutic use; Humans; Infertility, Female; drug therapy; etiology; Ovulation Induction; methods; Phytotherapy; Pregnancy; Pregnancy Rate; Yang Deficiency
- From: Chinese Journal of Integrated Traditional and Western Medicine 2012;32(7):882-884
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the therapeutic efficacy of combination of Compound Xuanju Capsule (CXC) and clomiphene citrate (CC) for ovulatory dysfunctional infertility (001) patients of Shen-yang deficiency syndrome (SYDS).
METHODSTotally 87 001 patients of SYDS were randomly assigned to 2 groups, the treatment group (44 cases, treated with CXC and CC) and the control group (43 cases, treated with CC alone). The post-treatment clinical symptoms, the cervical mucus, the endometrial thickness, the quality of follicles, the ovulation, and the pregnancy rate, and so on were observed.
RESULTSIn aspect of improving the patients' SYDS, the effective rate was 86.4% (38/44) in the treatment group and 25.6% (11/43) in the control group. It was better in the treatment group (P < 0.01). After treatment better effects on the cervical mucus, the endometrial thickness, and the pregnancy rate were obtained in the treatment group, showing statistical difference when compared with the control group (P < 0.05). There was no statistical difference in the rate of ovulation and mature follicular numbers between the two groups (P > 0.05).
CONCLUSIONCXC combined CC could ameliorate hypoestrinemia-like effects on the endometrium, increase the endometrial thickness, and be favorable to the pregnancy in treating ODI patients of SYDS.
